IBIO
$1.76
Ibio
($.09)
(4.86%)
IBIO
Earnings Whisper ®
N/A
3rd Quarter March 2021
Consensus:  $0.00
Revenue:  N/A
Tuesday
May 18
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when IBIO reports earnings?
Beat
Meet
Miss

Where is IBIO's stock price going from here?
Up
Flat
Down
Stock chart of IBIO
Analysts
Summary of analysts' recommendations for IBIO
Score
Grade
Pivots
Resistance
$1.98
$1.93
$1.85

$1.80

Support
$1.72
$1.67
$1.59
Tweet
Growth
Description
Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture of proteins applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus and veterinary influenza applications. IBio, Inc. is headquartered in Newark, Delaware.